Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and perflutren

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with perflutren in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(perflutren)
Trials
(perflutren)
Recent Studies (post-2010) (perflutren)
9,1561875521,17790467

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, S; Greener, Y; Jablonski, E; Killam, AL; Schmid-Schönbein, GW; Suematsu, M; Tojo, SJ; Yasu, T1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and perflutren

ArticleYear
Activated leukocytes and endothelial cells enhance retention of ultrasound contrast microspheres containing perfluoropropane in inflamed venules.
    International journal of cardiology, 2005, Feb-15, Volume: 98, Issue:2

    Topics: Animals; Blood Pressure; Endothelial Cells; Erythrocytes; Fluorocarbons; Heart Rate; Inflammation; Kinetics; Leukocytes; Male; Microcirculation; Microscopy, Fluorescence; Microspheres; Platelet Activating Factor; Rats; Rats, Wistar; Ultrasonography; Venules

2005